PAGE B RISK SCORE FOR HEPATOCELLULAR CARCINOMA HCC DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B CHB PATIENTS RECEIVING ENTECAVIR ETV OR TENOFOVIR TDF

Papatheodoridis G., Dalekos G., Sypsa V., YURTAYDIN S. C., Buti M., Goulis J., ...Daha Fazla

EASL 49th Annual Meeting of the International Liver Meeting, 9 - 13 Nisan 2014 identifier